Denmark continuously ranks within top 3 in the world on the Scientific American Scorecard for the development of biotechnology. Known for its focus on research and product development, Medicon Valley is home to more than 60% of Scandinavia’s pharmaceutical industry and is currently Europe’s fastest growing biotech cluster.
The Danish Novo Nordisk Foundation has awarded grants of more than €738 million to establish and expand their initiative, Copenhagen Bioscience Cluster, to establish world-class research centres in:
Part of the bioscience cluster is The Danish National Biobank being one of the world's largest biobanks ensuring scientists a comprehensive overview of and access to millions of biological samples in Denmark’s health care system.
Danish life science research is in top 5 within the OECD when measuring on citations, being cited almost twice as much as the world average*. Other life science areas where Greater Copenhagen has world-leading knowledge are:
-
Dementia and CNS related diseases
-
Reproduction and fertility
- Clinical Immunology (transfusion medicine)
-
Drug delivery systems
-
Bacteriology
-
Neuroscience
-
Oncology
-
Cardiology
-
Dermatology
-
Hearing aid solutions and related technologies
*Ministry of Higher Education and Science
